9 episodes

The Bleeding Edge of Digital Health is a podcast that spotlights the most innovative products, companies, & trends in the Digital Health segment of Med Tech.  
Host Mike Moore chats with the most iconic mavericks in Digital Health to showcase what they created that is so BLEEDING EDGE! 
The topics covered include the inspiration or “spark”, use case, why it’s unique, challenges overcome, mistakes made, desired impact, and much, much more!  
If you love Digital Health technology, THIS is the show for you!

The Bleeding Edge of Digital Health Mike Moore

    • Health & Fitness
    • 5.0 • 22 Ratings

The Bleeding Edge of Digital Health is a podcast that spotlights the most innovative products, companies, & trends in the Digital Health segment of Med Tech.  
Host Mike Moore chats with the most iconic mavericks in Digital Health to showcase what they created that is so BLEEDING EDGE! 
The topics covered include the inspiration or “spark”, use case, why it’s unique, challenges overcome, mistakes made, desired impact, and much, much more!  
If you love Digital Health technology, THIS is the show for you!

    medZERO: A FinTech App Making Healthcare Affordable

    medZERO: A FinTech App Making Healthcare Affordable

    In this week’s episode, host Mike Moore talks to Craig Froude, the CEO and co-founder of healthcare fintech app medZERO, which helps lower healthcare costs for employers and provides higher quality services to employees. 
    Many Americans can’t afford a surprise expense of $400 without going into debt – yet the average family will spend over $3200 in out-of-pocket health costs this year alone. 
    medZERO bridges that gap by giving employees on-demand access to funds to pay their out-of-pocket healthcare expenses over time—at zero interest and with zero fees. 
    Today, Mike and Craig discuss the state of the American healthcare system, Craig’s background at WebMD, how medZERO is helping make healthcare more accessible than ever and more.

    In This Episode

    (02:52) Setting the stage for medZERO 

    (05:51) Craig’s background at WebMD, and how he helped found medZERO

    (10:55) medZERO’s early challenges

    (17:42) How medZERO works

    (19:08) Two primary use cases

    (26:12) How medZERO benefits employers

    (30:15) medZERO’s development, and where it’s at now

    (36:13) The biggest challenges facing medZERO as it grows

    (42:31) How medZERO helps refinance medical debt


    Our Guest
    Craig Froude is the CEO of medZERO. Before that, he co-founded a technology-enabled health management company called WellMed. In 2002, WellMed successfully sold to WebMD, where Craig ran WebMD Health Services (WHS) for seven years as Executive Vice President/General Manager before becoming President in 2010. 

    Resources & Links
    Mike Moore

    https://www.linkedin.com/in/michaeljeffreymoore/

    https://www.linkedin.com/company/thebleedingedgeofdigitalhealth/


    The Bleeding Edge of Digital Health

    Apple Podcasts

    Google

    Amazon

    Spotify

    YouTube


    Craig Froude

    https://www.linkedin.com/in/craig-froude-5b9142/

    https://www.linkedin.com/company/medzero/

    https://medzero.com/

    • 52 min
    MedWand: The Swiss Army Knife of Telehealth

    MedWand: The Swiss Army Knife of Telehealth

    In this week’s episode, host Mike Moore talks to Dr. Sam Qamar, the Co-Founder, Chief Medical Officer, and former CEO of telehealth technology company MedWand Solutions.
    MedWand is a remote diagnostic device that helps providers conduct real-time examinations. Roughly the size of a computer mouse, MedWand provides live monitoring, remote clinical-grade vitals capture, and support for external AI-based vitals data analysis – all the tools a clinician needs for a comprehensive virtual exam. 
    Today, Mike and Sam discuss MedWand’s role in the future of telemedicine, how the stark differences between clinical medicine and telehealth paved the way for MedWand’s invention, and the challenges of bringing this revolutionary technology to life. 

    Notable Quotes
    “In the real world, if you come in with a cough and a fever, you would at least expect me to listen to your lungs, get your temperature, maybe get a pulse, make sure you don't have COVID perhaps – you expect an examination of sorts when you come in. In fact, you would probably think very differently about a doctor who didn't examine you or put their hands on you when you were sick and you would leave the office dissatisfied. Yet in telemedicine, we had shunned and basically ignored this whole critical component. The standard of care is to listen to someone's lungs is to get their temperature, get their vitals, get data. And that wasn't being done. [Telemedicine and clinical medicine] were both operating in parallel. And that bothered me as a doctor, as a futurist. So I decided to do something about it.” – Sam (05:32)

    In This Episode

    (02:10) The genesis of MedWand

    (06:29) Clinical medicine expectations vs telemedicine expectations

    (10:15) The engineering behind MedWand

    (15:15) The Swiss Army Knife of telehealth

    (19:48) “Borderless medicine” 

    (23:53) Star Trek, The Jetsons and modern medicine

    (25:35) The future of primary care

    (33:33) How MedWand works

    (41:50) The road to FDA approval

    (43:24) Revolutionizing the transition from hospital to home care


    Our Guest
    Dr. Sam Qamar is the Co-Founder, Chief Medical Officer, and former CEO of MedWand Solutions. Prior to MedWand, Sam founded Direct Primary Care company MedLion and worked with Google to help develop telemedicine technology. He completed his medical training at the University of Pennsylvania, and is a member of the MIT Tech Review Global Panel, AMA, and American Academy of Family Physicians. 

    Resources & Links
    Mike Moore

    https://www.linkedin.com/in/michaeljeffreymoore/

    https://www.linkedin.com/company/thebleedingedgeofdigitalhealth/


    The Bleeding Edge of Digital Health

    Apple Podcasts

    Google

    Amazon

    Spotify

    YouTube


    Sam Qamar 

    https://www.linkedin.com/in/samirqamar/

    https://www.linkedin.com/company/medwand-solutions/

    https://www.medwandsales.com/

    https://www.facebook.com/medwand/

    https://twitter.com/medwand/

    • 47 min
    Omniscient Neurotechnology: Connectomics, a Deeper Understanding of the Brain

    Omniscient Neurotechnology: Connectomics, a Deeper Understanding of the Brain

    In this week’s episode, host Mike Moore speaks with Stephen Scheeler, the CEO and Managing Director of brain data company Omniscient Neurotechnology. 
    Omniscient uses aritifical intelligence and a new field of neurotechnology called connectomics to create a digital map of the brain, known as a connectome, to better understand and eventually design unique treatments for conditions like depression, Alzheimer’s, schizophrenia and stroke. 
    Today, Stephen talks about how brain mapping works, the science behind connectomics, and the vast human potential Omniscient Neurotechnology is hoping to unlock. 

    Notable Quotes

    “They said, this changes everything. This changes our understanding of the human brain so fundamentally that it's gonna unlock all kinds of human potential over the next, you know, hundred years. And when you have people with this caliber tell you those things, you take pause. And so we started to talk about how we could maybe work together. I started helping them figure out their business model. I went to China to talk to some of the researchers that were already working in that market. And I got more and more fascinated and just saw the potential of what we were trying to build. So I kind of got more and more involved.” – Stephen (10:35)

    “Everybody, every wiring, every building is a little different. And so what we do is we bring those wiring maps. We build those maps so that if you have pain or you forgot where you left your keys, or you're feeling a little anxious or depressed or whatever, if you're suicidal, if it's that severe, we can map that. And we can show where in your connectome, in your wiring, the problem lies. And so that's a complete transformation for everything we do about the human brain today.” – Stephen (15:31)


    In This Episode

    (01:33) Stephen’s background

    (04:15) The genesis of Omniscient Neurotechnology

    (08:45) Neuroscience, AI and the field of connectomics 

    (13:01) What is connectomics? 

    (16:16) Connectomics and mental health treatment

    (17:31) How brain mapping works

    (27:10) The economic benefits and human potential of Omniscient Neurotechnology

    (29:44) Psychedelics and neuroscience

    (35:26) The surgical implications

    (48:56) The future of Omniscient

    (51:30) Omniscient’s biggest challenges


    Our Guest
    Stephen Scheeler is the CEO and Managing Director of brain data company Omniscient Neurotechnology. Previously, he served as the CEO of Facebook for Australia and New Zealand. 
    Stephen is also the founder of global advisory The Digital CEO, Senior Advisor to McKinsey & Company, and Executive-in-Residence at Asia-Pacific’s leading business school, the Australian Graduate School of Management. 
    He has advised the leaders of Qantas, Suncorp, Telstra, Wesfarmers, AMP, CUB, Brambles, Google, and the Australian Government. Stephen is also a member of the Australian Prime Minister's Knowledge Nation 100 as one of Australia’s top innovation leaders. 

    Resources & Links
    Mike Moore

    https://www.linkedin.com/in/michaeljeffreymoore/

    https://www.linkedin.com/company/thebleedingedgeofdigitalhealth/


    The Bleeding Edge of Digital Health

    Apple Podcasts

    Google

    Amazon

    Spotify

    YouTube


    Stephen Scheeler

    https://www.linkedin.com/in/stephenscheeler/?originalSubdomain=au

    https://www.linkedin.com/company/omniscientneurotechnology/

    https://www.o8t.com/

    • 58 min
    Us2.ai: A.I. Brings Clarity to Cardiac Ultrasound, and Beyond

    Us2.ai: A.I. Brings Clarity to Cardiac Ultrasound, and Beyond

    Historically, echo analysis has been too expensive or inaccessible for many heart disease patients to receive the care they need. Today’s guests, James Hare and Dr. Carolyn Lam of Us2.ai, are changing that. 
    Us2 is a decision support tool that uses artificial intelligence to automate reading any DICOM (Digital Imaging and Communications in Medicine), anytime, from any device. 
    It is FDA-cleared, vendor-agnostic, and delivers peer-reviewed results that are shown to be interchangeable with expert human sonographers. 
    Us2’s mission is to give everyone full access to their heart health with easy, mobile echo analysis.
    Today, James and Dr. Lam discuss why echos can be tricky even for medical experts to get right, how Us2 supports both physician and patient use across a variety of cardiac conditions and the healthcare democratization movement. 

    Notable Quotes

    “It should be accessible to everybody to look at the heart. Why shouldn't you be able to look at the heart and see you've got a hole in your heart or a part of the heart that's not working well or a valve is not working well? I mean, we should be able to do that everywhere.” – Dr. Carolyn Lam (04:02)

    “There's a lot of well merited skepticism about new AI technologies and the burden is on us to prove that what we have done is useful and it works. But once we push beyond that, once people actually see it, it's just the best feeling in the world. And the reality is that everybody in this, as skeptical as they are, everyone knows what the future is. It's just a matter of how soon we're gonna get there.” – James Hare (18:37)


    In This Episode

    (03:36) Us2’s origins 

    (15:20) How it works

    (19:40) Use cases and the intricacies of heart failure that Us2 can identify 

    (25:38) Us2 uses beyond heart failure

    (31:30) Us2’s commercial outlook 

    (33:25) The biggest challenge during Us2’s development

    (35:13) Finding a shared language across business, medicine and tech

    (39:05) The future of Us2 in hospitals and physician offices


    Our Guests
    Us2.ai CEO and Co-founder James Hare previously served as the Co-founder and President of eDreams, which IPO’d in 2014 and has become one of the world’s most successful e-commerce sites. Before starting Us2, James worked at organizations including EFI, UbiSoft and Netscape, and earned his MBA from Stanford and BA from Harvard.
    Dr. Carolyn Lam is the Co-founder & Non-Exec Head of Medical Affairs, and is a tenured Professor at Duke-National University in Singapore, where she founded and continues to run the first Women’s Heart Clinic. Dr. Lam received her Masters from the Mayo Clinic, graduated from the Stanford Executive Program and then earned her PhD from the University Medical Center Groningen in the Netherlands.

    Resources & Links
    Mike Moore
    LinkedIn

    James Hare
    LinkedIn

    Dr. Carolyn Lam
    LinkedIn

    Us2.AI 

    Website

    LinkedIn


    The Bleeding Edge of Digital Health

    Apple Podcasts

    Google

    Amazon

    Spotify

    YouTube

    LinkedIn

    • 44 min
    MedScout: Med-Tech’s Premier Revenue Acceleration Platform

    MedScout: Med-Tech’s Premier Revenue Acceleration Platform

    In this week’s episode, host Mike Moore talks with MedScout co-founder and CEO Skylar Talley about an innovative, intuitive new platform tailor-made to help life sciences companies go to market and grow at scale. 
    With MedScout, sales teams can easily access everything they need to drive sales. Seamlessly integrated with your CRM, reps can find the latest medical procedural data, optimize territories, uncover deep insights about a physician's practice or facility's operations, and manage prospect lists, all in one place. 
    Today, Skylar shares a live demo of MedScout, its mobile app, the targeting criteria system, pipeline capabilities and more. 

    Notable Quotes
    “The thinking is that once we understand you're targeting criteria, we're ingesting all this data on a regular basis. And if things like that change, if a new payer comes in, if they get into a new procedural area, eventually we wanna be to the point where we're proactively notifying you about that. And then updating all the systems, according to how you want your sales process instrumented. We want to take that manual work out of something that the rep has to do on a regular basis.” – Skylar (24:27)

    “We wanted to build something that was gonna help the reps in the field. And then the idea obviously is you can come in, have a great visit with Dr. Silver, take notes really quickly, let's say, follow up Monday, save, and then that's gonna sink down to your CRM and then you don't have to worry about going in and filling out Salesforce or anything whenever you get back to the hotel. …  You're out in the field often. So we felt like this mobile app component was gonna be big and we wanted to get that right from the start and also get it into people's hands and get feedback. Hey, what would be helpful in the app for you? So, yeah, pretty proud of that.” – Skylar (34:45)

    In This Episode

    (02:43) How MedScout helps life sciences companies create more effective sales plans

    (05:14) MedScout’s origins 

    (09:52) “Tactical visibility,” territory modeling, and getting tech to market faster

    (11:44) The longstanding problems MedScout solves in the medtech space

    (17:23) The MedScout demo – mobile app, onboarding process, targeting criteria, pipeline and more

    (26:39) How MedScout works to drive revenue at scale 

    (30:15) Dynamic management of rep teams in-app

    (36:00) MedScout’s target customers and pricing

    (40:06) MedScout’s differentiators – built for individual reps, usability and simplicity 

    (43:41) MedScout’s future endeavors


    Our Guest
    Skylar Talley is the co-founder and CEO of MedScout. After earning a degree in finance from UT Austin, Skylar worked at startups including Storable, Waldo Photos, and AlienVault, which was purchased by AT&T and now forms a significant portion of AT&T’s business cybersecurity division. 

    Resources & Links
    Mike Moore

    https://www.linkedin.com/in/michaeljeffreymoore/

    https://www.linkedin.com/company/thebleedingedgeofdigitalhealth/


    Skylar Talley and MedScout

    https://www.linkedin.com/in/skylar-talley-28558767/

    https://www.linkedin.com/company/medscout-inc/

    https://www.medscout.io/


    The Bleeding Edge of Digital Health

    Apple Podcasts

    Google

    Amazon

    Spotify

    YouTube

    • 48 min
    Lazurite: The World's Only Wireless Endoscopic Camera

    Lazurite: The World's Only Wireless Endoscopic Camera

    In today’s episode, host Mike Moore sits down with Eugene Malinskiy, CEO and co-founder of medtech firm Lazurite, whose cutting-edge ArthroFree™ System is poised to revolutionize surgery both for surgeons and their patients. 
    ArthroFree™ is the world’s first fully wireless, minimally invasive, FDA-approved surgical camera. Its cableless setup means surgeons can work freely, while also simplifying the sterile field and minimizing setup and takedown process. 
    ArthroFree™’s endoscopic visualization system seamlessly integrates into existing OR workflows for more efficient procedures and better patient outcomes. 
    Today, Eugene talks about designing ArthroFree™ with surgeon feedback, the current state of medtech and the future of wireless OR technology.

    Notable Quotes

    “The docs have gotten better at doing the procedures, but they're using equipment that was really created and commercialized 30 years ago. … You have cables that are going across the surgical field, across the patient and into the surgeons or the staff's hands. And these cables have always existed. And it's kind of crazy because … there's really been no major change in how these procedures are actually done [in the last 30 years]. And so what we've done is we've created the world's first wireless camera system to try to eliminate and try to start eliminating those cables.”  – Eugene (07:07)

    “I went around and showed this to surgeons. And they said, ‘Oh my God, you think you could actually solve wireless?’ I'm like, ‘I think I can.’ And they said, ‘That's fantastic. We've been wanting this for the last 10 or 20 years.’ And then I asked them because we've always prided ourselves on taking feedback from our champions, from the surgeons, the nurses, the facilities, the innovators, right. We wanted to make sure we were building something that they want.” – Eugene (35:27)


    In This Episode

    (02:01) What ArthroFree™ is and how it works

    (04:47) The current state of the medical industry, and where ArthroFree™ fits in

    (22:23) Challenges during ArthroFree™’s development

    (28:03) The wireless problem

    (38:37) Procedures ArthroFree™ revolutionizes

    (43:45) ArthroFree™’s target market

    (49:36) The importance of physician feedback in ArthroFree™’s development


    Our Guest
    Eugene Malinskiy is the CEO and co-founder of medtech firm Lazurite. Before Lazurite, he served as the CEO and founder of DragonID, a biomedical engineering firm specializing in orthopedic and cardiology devices.
    Eugene received his MS in Biomedical Engineering from Cleveland State University. In 2015, he was named one of Forbes’ 30 Under 30 in Manufacturing & Industry.

    Resources & Links
    Mike Moore

    https://www.linkedin.com/in/michaeljeffreymoore/

    https://www.linkedin.com/company/thebleedingedgeofdigitalhealth/


    Eugene Malinskiy 
    https://www.linkedin.com/in/emalinskiy/

    Lazurite

    https://www.linkedin.com/company/lazuritelabs/

    https://lazurite.co/arthrofree/


    The Bleeding Edge of Digital Health

    Apple Podcasts

    Google

    Amazon

    Spotify

    YouTube

    • 55 min

Customer Reviews

5.0 out of 5
22 Ratings

22 Ratings

AJ Gopal ,

Awesome Podcast

I binged listened to almost all your shows this week and feel so much more informed and educated about the digital medtech world! You’re an awesome interviewer Mike. Keep up the great and meaningful work.

D1315 ,

Important insights

With so many podcasts to try, I find that most give me an insight or two but not enough to compel me to subscribe and anticipate. This podcast does and consistently delivers.

Jmack123456 ,

Worth it

Mike is brilliant and bold. I love his style.

You Might Also Like